EarlyHealth supports manufacturers in offering patients access to treatments not yet registered in their country. Due to high product development costs, manufacturers tend to register newly developed medicines initially in the USA followed by Europe. Some medicines takes years before the budget and healthcare infrastructure is in place to expand in new markets.
We ensure that unmet patients have access to medication under compassionate use / name patient programs, and that the regulatory, import formalities and distribution partners are synchronized for quick and safe delivery to treating facilities.
Brazil patient urgently requiring new treatment, available in USA, for spinal muscular atrophy.
Newly registered treatment for spinal muscular atrophy, a rare neuromuscular disorder, required urgently for baby in Brazil.
Working closely with manufacturer to ensure patient in Qatar received treatment for inborn urea cycle disorders.
Medication used to treat medullary thyroid cancer and a second line treatment for renal cell carcinoma required by Swiss patient.
Chemotherapy drug used in T-cell acute lymphoblastic leukemia required for patient treatment at cancer hospital.
Urgent requirement of medicine for relapsed or refractory cutaneous T-cell lymphoma (CTCL) patient at hospital.
Medicine required by patient for combination therapy to treat brain tumor glioblastoma.
Newly registered product to treat relapsed acute myeloid leukemia for a patient with specific mutations.
Patients requiring modern medicine to treat relapsed or refractory Hodgkin lymphoma.
Japanese medication used to help a French patient recover following a stroke and treat his amyotrophic lateral sclerosis.
Vital combination medicine required for chemotherapy treatment in young patient.
Patient in Saudi Arabia requiring immunotherapy to treat unresectable Stage 3 non-small cell lung cancer (NSCLC).
Patient needing new treatment for relapsing multiple sclerosis in Chile.
With access to over 25,000 healthcare products from USA, Europe and Asia, EarlyHealth can assist you in not only obtaining your medication, but also organizing the import regulations with local health authority; customs formalities and GDP delivery to your physician, as per your domestic health authority allowances under compassionate use / name patient program.